Evidence map›Paper›PMID 38049194›Full record

ReviewBritish journal of haematology2024

The metabolic basis of inherited neutropenias.

Usua Oyarbide, Genevieve M Crane, Seth J Corey

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in British journal of haematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Barth Syndrome:Genes · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Usua OyarbideDepartment of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0003-4082-7945
Genevieve M CraneDepartment of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Seth J CoreyDepartment of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-3575-6401
Cleveland Clinic · US

Funding

Multiscale Modeling of Myelodysplastic SyndromesR01HL128173 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI COREY, SETH JOEL, KIMMEL, MAREK · 2015 to 2019
$3.8M
Genetic Dissection of Stress Responses in Shwachman-Diamond SyndromeR01DK132812 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI COREY, SETH JOEL · 2023 to 2025
$701k
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AMLR21CA159203 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI COREY, SETH JOEL · 2014 to 2015
$374k
NCI NIH HHS R01 DK132812NCI NIH HHS R01 HL128173NCI NIH HHS R21 CA159203NHLBI NIH HHS HL128173NHLBI NIH HHS R01 HL128173NIDDK NIH HHS DK132812NIDDK NIH HHS R01 DK132812
6 · The paper itself

Abstract

Neutrophils are the shortest-lived blood cells, which requires a prodigious degree of proliferation and differentiation to sustain physiologically sufficient numbers and be poised to respond quickly to infectious emergencies. More than 10

Indexed as

Bone Marrow DiseasesFanconi AnemiaNeutropeniaAdaptor Proteins, Signal TransducingAdultAntiportersBone MarrowBone Marrow Failure DisordersHumansMonosaccharide Transport ProteinsAdaptor Proteins, Signal TransducingAntiportersHAX1 protein, humanMonosaccharide Transport ProteinsSLC37A4 protein, humancellular metabolismgenetic disordersneutropenianeutrophils

Identifiers

PMID38049194
PMCPMC12236450
OpenAlexW4389323618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.